Brand / product

Rifampicin + INH

Rifampicin + Isoniazid · 300 mg + 150 mg

ShareSend this page
Official source-observed price PKR 66.92 8’s
PKR 8.37 / capsule
✓ Official DRAP price source observed · Source checked 2026-09-23
Price Intelligence

Equivalent price position

Same generic · strength · dosage form · compatible unitPrice Intelligence PRO
This brandPKR 8.37/ capsule
Price positionNear medianvs like-for-like peer median
Peer comparators1current-price listings
🔒
MedInfoBase Pharma Pro

Unlock the full competitive price benchmark

See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.

Rank & percentilePeer medianFull competitor listPortfolio intelligence
View Price Intelligence PRO

Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.

Product details

Generic
Rifampicin + Isoniazid
Therapeutic area
Anti-infectives
Drug class
Antimycobacterials
ATC
J04AM
Strength
300 mg + 150 mg
Dosage form
Capsule
Pack
8’s
Registration no.
009785
Price record verified
2026-08-09
Latest DRAP source check
2026-09-23 03:18

Manufacturer

Zafa Pharmaceutical Laboratories (Pvt) Ltd.

Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.

View company portfolio →
Price movement

Official price over time

No change in the official DRAP price is recorded for this pack (8’s). Current price PKR 66.92, effective 27 Jul 2026.

Cite this price history

MedInfoBase. Rifampicin + INH 300 mg + 150 mg, 8’s: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/rifampicin-inh-300-mg-150-mg-009785-30s-zafa-pharmaceutical-laboratories-pvt-ltd/ (accessed 23 September 2026).

Traceability

Official price history

AmountEffective fromVerifiedSourceStatus
PKR 66.922026-07-272026-08-09DRAP PharmaPrice IndexCurrent
Same generic

Other listed brands

Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.

Cite this record

Medicine record · DRAP registration 009785
MedInfoBase. (2026). Rifampicin + INH 300 mg + 150 mg Capsule (8’s), Zafa Pharmaceutical Laboratories (Pvt) Ltd. — registration and price record [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/brand/rifampicin-inh-300-mg-150-mg-009785-30s-zafa-pharmaceutical-laboratories-pvt-ltd/ Data observed 9 August 2026. Source: DRAP PharmaPrice Index. DRAP registration 009785.
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.